TXMD,TherapeuticsMD, Inc. | Healthcare

Healthcare

TXMD

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

TherapeuticsMD, Inc.TXMD

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

TherapeuticsMD, Inc. operates as a pharmaceutical company in the United States.

It has a license agreement with Mayne Pharma to commercialize the IMVEXXY,BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands.

The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors.

TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Latest News >

Savara Q4 Loss Unchanged From Year Earlier

Mar 13, 2026

08:43 AM EDT, 03/13/2026 (MT Newswires) -- Savara (SVRA) reported a Q4 loss Friday of $0.13 per diluted share, unchanged from a year earlier. Analysts polled by FactSet expected a loss of $0.12. The company reported no revenue for the quarter ending Dec. 31. Cash, cash equivalents, and short-term investments as of Dec. 31 totaled $235.7 million, up from $196.3...

Trulieve Cannabis to Open Medical Cannabis Dispensary in DeLand, Florida

Mar 13, 2026

08:44 AM EDT, 03/13/2026 (MT Newswires) -- Trulieve Cannabis ( TCNNF ) on Friday announced the opening of a new medical cannabis dispensary in DeLand, Florida. The company said that the new dispensary will carry a wide variety of popular products including Trulieve's portfolio of in-house brands such as Co2lors, Cultivar Collection, Modern Flower, Momenta, Roll One, and Sweet Talk....

Traders bet on Fed rate cut by September

Mar 13, 2026

March 13 (Reuters) - The Federal Reserve will probably next cut interest rates in September, traders bet on Friday after government data showed inflation by the Fed's targeted measure wasn't quite as hot as feared at the start of the year. Before the data, which showed a 2.8% year-on-year rise in the personal consumption expenditures price index in January, the...

BioDlink Named "Emerging CDMO of the Year" at the 2026 Asia-Pacific Biopharma Excellence Awards

Mar 13, 2026

BioDlink has been named Emerging CDMO of the Year for its innovation in complex biologics and ADC development.The award recognizes its proprietary technology platforms, scalable manufacturing, and a proven quality system with over 100 audits completed.SUZHOU, China, March 13, 2026 /PRNewswire/ -- BioDlink, an innovation-driven Contract Development and Manufacturing Organization (CDMO), today announced that it has been named Emerging CDMO...